StonvexLoading…
StonvexCore line items from CSAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | BRL 43.95B | BRL 39.47B | BRL 39.32B | BRL 26.09B |
Operating Income | BRL 7.69B | BRL 10.96B | BRL 7.48B | BRL 4.09B |
Net Income | BRL -8.16B | BRL 4.88B | BRL 2.82B | BRL 6.70B |
EPS (Diluted) | BRL -5.16 | BRL 0.58 | BRL 0.63 | BRL 3.43 |
Total Assets | BRL 141.27B | BRL 139.87B | BRL 134.48B | BRL 97.84B |
Total Liabilities | BRL 101.87B | BRL 88.88B | BRL 86.32B | BRL 68.97B |
Cash & Equivalents | BRL 16.90B | BRL 14.66B | BRL 13.30B | BRL 16.17B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available |